Monoclonal gammopathy is characterized by an abnormal monoclonal (M)-protein in the blood. This protein is associated with renal toxicity related to the underlying gammopathy. "The key finding of our ...
Dear Dr. Roach: Would it be possible for you to explain my recent diagnosis of monoclonal gammopathy of uncertain significance (MGUS)? Apparently, 3% to 5% of the population over the age of 50 show ...
Monoclonal gammopathy of undetermined significance was diagnosed in 213 Mayo Clinic patients from 1960 to 1994 who were residents of 11 counties in southeastern Minnesota.2,6 Fifty-eight percent of ...
Patients with multiple myeloma appear to have better survival if they are found to have monoclonal gammopathy of undetermined significance first, the state that precedes MM and which is typically ...
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma are both precursor conditions that can turn into multiple myeloma, a type of cancer that affects plasma cell production ...
Response Assessment of Aggressive Non-Hodgkin’s Lymphoma by Integrated International Workshop Criteria and Fluorine-18–Fluorodeoxyglucose Positron Emission Tomography We evaluated 217 patients with ...
Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to protect us from infections. However, the cells grow too much in myeloma, crowding ...
Watch Dr. Neha S. Korde, an assistant professor in multiple myeloma service in the Division of Hematology at Memorial Sloan Kettering Cancer Center, present on MGUS/smoldering myeloma. Multiple ...
GLP-1RA use was associate with lower risks for cardiovascular events among patients with monoclonal gammopathy of undetermined significance and type 2 diabetes. Use of glucagon-like peptide-1 receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback